Pediatric Emergency Suture Care: a Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA (Hypno-Mo)
Primary Purpose
Wounds, Nonpenetrating
Status
Recruiting
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Use of MEOPA during suturing
Use of Hypnosis during suturing
Stitch removal
Sponsored by
About this trial
This is an interventional treatment trial for Wounds, Nonpenetrating
Eligibility Criteria
Inclusion Criteria:
- The patient was informed about the implementation of the study, its objectives, constraints and patient rights
- The legal representative of the patient must have given free and informed consent and signed the consent
- The patient must be affiliated with or beneficiary of a health insurance plan
- The patient is available for 15 days of follow-up
- The patient is consulting in the emergency department for a wound requiring the completion of a suture and for which the operator considers that the use of nitrous oxide is necessary and possible.
Exclusion Criteria:
- The patient is participating in another interventional study
- The patient has participated in another interventional study in the last 3 months
- The patient is in an exclusion period determined by a previous study
- The patient and/or his/her parents (or legal representative) refuses to sign the consent
- It proves impossible to correctly inform the patient and / or his/her parents (or legal representative)
- The patient has a contra-indication (or an incompatible drug combination) for a treatment required in this study (MEOPA): intracranial hypertension, impaired consciousness, pneumothorax, high rate oxygen-dependence, facial trauma preventing mask application.
- The patient has a condition that makes hypnosis impossible: e.g. encephalopathy, deafness, communication disorders, does not speak French
- Suture requiring surgical exploration or an operating room, or general anesthesia or an ears-nose-throat, orthopedic or visceral surgeon (e.g. wound of the oral cavity, abdominal or thoracic penetrating wound, finger or palm wound requiring exploration by an orthopaedist)
- Fractures associated with wound
- Use of level II/III analgesics before the beginning of pre-suture care support
Sites / Locations
- CHRU de Nîmes - Hôpital Universitaire CarémeauRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Usual care (MEOPA)
Experimental arm (Hypnosis)
Arm Description
Patients randomized to this arm will receive usual care, including MEOPA inhalation during local anesthetic injection and suturing. Intervention: Use of MEOPA during suturing Intervention: Stitch removal
Patients randomized to this arm will receive usual care as in the other arm, but before MEOPA inhalation is started, hypnosis will be tried. The local anesthetic injection and suturing will therefore take place under hypnosis (and MEOPA if necessary). Intervention: Use of Hypnosis during suturing Intervention: Stitch removal
Outcomes
Primary Outcome Measures
Failure of pain control: yes/no
Failure of pain control as defined by:
The conversion of the procedure to MEOPA (for the hypnosis arm) or to sedation (for the MEOPA arm. Conversion is decided if the FLACC score at the end of the induction phase of hypnosis or for MEOPA is greater than 3 (1-3 are equivalent to mild discomfort).
Or a FLACC score> 3 during the period between anesthetic injection and the end of the suture.
The FLACC score
Secondary Outcome Measures
Pain as measured via a VAS score for children over six years of age
Score varying from 0.0 to 10.0
The EVENDOL score
time lapsed between the beginning of the procedure and end of the suture
Beginning of procedure: defined as either the beginning of MEOPA administration, or the beginning of hypnosis
End of suture: the suture is declared as finished after cleaning the sutured zone, removal of drapes and placement of wound dressing
time lapsed between the beginning of the procedure and the beginning of the suture
Beginning of procedure: defined as either the beginning of MEOPA administration, or the beginning of hypnosis
Beginning of the suture: defined as the beginning of the first stitch
MEOPA use
measured as litres/minute x minutes of administration
Qualitative scale for general suturing conditions
classified as verg good, good, correct, or bad
Use of physical restraint? yes/no
Procedure failure: yes/non
i..e, was it necessary to resort to complementary means in order to perform the suture?
Visual analog scale for operator satisfaction in relation to the performed procedure
Visual analog scale for operator's perception of the ease of the procedure
Visual analog scale for parental satisfaction concerning pain care and comfort during suturing
Only one VAS per child
Visual analog scale for pain (only for children over 6)
The EVENDOL scale for pain
The FLACC scale for pain
Visual analog scale for operator's perception of the ease of stich removal
the child's behaviour during stitch removal
classified as: calm; afraid but capable of self-control; complementary means required
The presence/absence of complications
The presence/absence of at least one of the following complications: vomiting, nausea, agitation, imbalance problems, headache, persistant anesthesia at the end of the procedure.
Full Information
NCT ID
NCT02420002
First Posted
April 14, 2015
Last Updated
October 10, 2023
Sponsor
Centre Hospitalier Universitaire de Nīmes
1. Study Identification
Unique Protocol Identification Number
NCT02420002
Brief Title
Pediatric Emergency Suture Care: a Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA
Acronym
Hypno-Mo
Official Title
Suture Care in the Pediatric Emergency Department: a Randomized Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 25, 2016 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
January 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Nīmes
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a therapeutic, randomized, single center, two parallel-arm trial comparing pain control via "MEOPA" (equimolar mixture of nitrous oxide and oxygen) in one arm versus "Hypnosis + MEOPA if needed" in the second arm.
The primary objective is to compare the two study arms in terms of efficacity for pain control according to the FLACC (Face Legs Activity Cry Consolability Observational Tool) behavioural scale.
Detailed Description
The secondary objectives of this study are to compare the two study arms in terms of:
Efficacity for pain relief during suturing according to other validated scales (a visual analog scale (VAS), the EVENDOL (Evaluation Enfant Douleur) scale);
the duration of the procedure, the time between the start of the care process for pain (hypnosis or nitrous oxide) and the beginning of the suture;
the amount of nitrous oxide administered;
the conditions under which suturing takes place, in terms of (i) the general conditions of implementation, (ii) the need to use physical restraint, (iii) failure of the procedure and the need to resort to supplementary means of anesthesia, (iv) satisfaction of the operator and his/her perceived ease of operations, (v) satisfaction of the parents;
the behavior of the patient during removal of the suture;
the conditions under which suture removal takes place;
complications related to the used treatments.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wounds, Nonpenetrating
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Usual care (MEOPA)
Arm Type
Active Comparator
Arm Description
Patients randomized to this arm will receive usual care, including MEOPA inhalation during local anesthetic injection and suturing.
Intervention: Use of MEOPA during suturing Intervention: Stitch removal
Arm Title
Experimental arm (Hypnosis)
Arm Type
Experimental
Arm Description
Patients randomized to this arm will receive usual care as in the other arm, but before MEOPA inhalation is started, hypnosis will be tried. The local anesthetic injection and suturing will therefore take place under hypnosis (and MEOPA if necessary).
Intervention: Use of Hypnosis during suturing Intervention: Stitch removal
Intervention Type
Drug
Intervention Name(s)
Use of MEOPA during suturing
Other Intervention Name(s)
equimolar mixture of nitrous oxide and oxygen
Intervention Description
Patients randomized to this arm will receive usual care, including MEOPA inhalation during local anesthetic injection and suturing of a wound.
Intervention Type
Other
Intervention Name(s)
Use of Hypnosis during suturing
Intervention Description
Patients randomized to this arm will receive usual care as in the other arm, but before MEOPA inhalation is started, hypnosis will be tried. The local anesthetic injection and suturing of the wound will therefore take place under hypnosis (and MEOPA if necessary).
Intervention Type
Procedure
Intervention Name(s)
Stitch removal
Intervention Description
6 to 15 days after the initial suturing, stitches will be removed according to usual procedures.
Primary Outcome Measure Information:
Title
Failure of pain control: yes/no
Description
Failure of pain control as defined by:
The conversion of the procedure to MEOPA (for the hypnosis arm) or to sedation (for the MEOPA arm. Conversion is decided if the FLACC score at the end of the induction phase of hypnosis or for MEOPA is greater than 3 (1-3 are equivalent to mild discomfort).
Or a FLACC score> 3 during the period between anesthetic injection and the end of the suture.
Time Frame
baseline (day 0)
Title
The FLACC score
Time Frame
day 0, during anesthetic injection
Secondary Outcome Measure Information:
Title
Pain as measured via a VAS score for children over six years of age
Description
Score varying from 0.0 to 10.0
Time Frame
day 0, during anesthetic injection
Title
The EVENDOL score
Time Frame
day 0, during anesthetic injection
Title
time lapsed between the beginning of the procedure and end of the suture
Description
Beginning of procedure: defined as either the beginning of MEOPA administration, or the beginning of hypnosis
End of suture: the suture is declared as finished after cleaning the sutured zone, removal of drapes and placement of wound dressing
Time Frame
day 0
Title
time lapsed between the beginning of the procedure and the beginning of the suture
Description
Beginning of procedure: defined as either the beginning of MEOPA administration, or the beginning of hypnosis
Beginning of the suture: defined as the beginning of the first stitch
Time Frame
day 0
Title
MEOPA use
Description
measured as litres/minute x minutes of administration
Time Frame
day 0
Title
Qualitative scale for general suturing conditions
Description
classified as verg good, good, correct, or bad
Time Frame
day 0
Title
Use of physical restraint? yes/no
Time Frame
day 0
Title
Procedure failure: yes/non
Description
i..e, was it necessary to resort to complementary means in order to perform the suture?
Time Frame
day 0
Title
Visual analog scale for operator satisfaction in relation to the performed procedure
Time Frame
day 0
Title
Visual analog scale for operator's perception of the ease of the procedure
Time Frame
day 0
Title
Visual analog scale for parental satisfaction concerning pain care and comfort during suturing
Description
Only one VAS per child
Time Frame
day 0
Title
Visual analog scale for pain (only for children over 6)
Time Frame
during stitch removal (days 6 to 15)
Title
The EVENDOL scale for pain
Time Frame
during stitch removal (days 6 to 15)
Title
The FLACC scale for pain
Time Frame
during stitch removal (days 6 to 15)
Title
Visual analog scale for operator's perception of the ease of stich removal
Time Frame
during stitch removal (days 6 to 15)
Title
the child's behaviour during stitch removal
Description
classified as: calm; afraid but capable of self-control; complementary means required
Time Frame
during stitch removal (days 6 to 15)
Title
The presence/absence of complications
Description
The presence/absence of at least one of the following complications: vomiting, nausea, agitation, imbalance problems, headache, persistant anesthesia at the end of the procedure.
Time Frame
day 0
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The patient was informed about the implementation of the study, its objectives, constraints and patient rights
The legal representative of the patient must have given free and informed consent and signed the consent
The patient must be affiliated with or beneficiary of a health insurance plan
The patient is available for 15 days of follow-up
The patient is consulting in the emergency department for a wound requiring the completion of a suture and for which the operator considers that the use of nitrous oxide is necessary and possible.
Exclusion Criteria:
The patient is participating in another interventional study
The patient has participated in another interventional study in the last 3 months
The patient is in an exclusion period determined by a previous study
The patient and/or his/her parents (or legal representative) refuses to sign the consent
It proves impossible to correctly inform the patient and / or his/her parents (or legal representative)
The patient has a contra-indication (or an incompatible drug combination) for a treatment required in this study (MEOPA): intracranial hypertension, impaired consciousness, pneumothorax, high rate oxygen-dependence, facial trauma preventing mask application.
The patient has a condition that makes hypnosis impossible: e.g. encephalopathy, deafness, communication disorders, does not speak French
Suture requiring surgical exploration or an operating room, or general anesthesia or an ears-nose-throat, orthopedic or visceral surgeon (e.g. wound of the oral cavity, abdominal or thoracic penetrating wound, finger or palm wound requiring exploration by an orthopaedist)
Fractures associated with wound
Use of level II/III analgesics before the beginning of pre-suture care support
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Philippe Fournier, MD
Phone
+33.(0)4.66.68.30.50
Email
philippe.fournier@chu-nimes.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Carey M Suehs, PhD
Phone
+33.(0)4.66.68.67.88
Email
carey.suehs@chu-nimes.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe Fournier, MD
Organizational Affiliation
Centre Hospitalier Universitaire de Nîmes
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHRU de Nîmes - Hôpital Universitaire Carémeau
City
Nîmes Cedex 09
ZIP/Postal Code
30029
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Philippe Fournier, MD
First Name & Middle Initial & Last Name & Degree
Tu Anh Tran, MD, PhD
12. IPD Sharing Statement
Learn more about this trial
Pediatric Emergency Suture Care: a Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA
We'll reach out to this number within 24 hrs